Analysed ASTELLAS PHARMA INC (ALPMF:OTCMKTS) News Sources
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
02-09-2026
yahoo.com
Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer
23-09-2026
yahoo.com
ARTHEx Biotech Announces Appointment of Glenn P. Sblendorio as Chairman of the Board
29-09-2026
yahoo.com
New Preliminary Real-World VEOZAH™ (fezolinetant) Data Highlights Improvements in Menopause-Related Symptoms and Sleep Outcomes
02-10-2026
yahoo.com
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
06-10-2026
yahoo.com
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
08-10-2026
yahoo.com
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
13-10-2026
yahoo.com
What is the current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is $13.1.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is $-2.2.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is -14.3791%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC (ALPMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.